MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4081/dr.2025.10315

Медицинская библиотека · Dermatology reports · 2025

Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy.

May Lee Marco, Di Lernia Vito, Peccerillo Francesca, Bardazzi Federico, Tabanelli Michela, Ricci Michela, Melandri Davide, Corazza Monica, Satolli Francesca, Conti Andrea

СтатьяПеревод пока не подготовлен

Аннотация

Adalimumab (ADA), a monoclonal antibody targeting tumor necrosis factor (TNF)-α, is effective in treating moderate to severe psoriasis. The emergence of biosimilars, such as GP2017 (Hyrimoz®, Sandoz GmbH), has raised concerns about their safety and efficacy compared to the originator. This two-year observational study evaluated the effectiveness and safety of GP2017 in 171 patients from Emilia-Romagna, Italy. Patients were divided into two groups: 78 transitioned from the ADA originator, and 93 were biologic-naive. Changes in the Psoriasis Area and Severity Index (PASI) were analyzed. In the switch group, PASI scores remained stable, while the naive group achieved significant improvements (PASI 75: 52% at 3 months, 89% at 6 months). Adverse events leading to discontinuation were rare. The findings confirm that GP2017 is as effective and safe as the ADA originator, supporting its use as a cost-effective alternative in the treatment of psoriasis. Biosimilars play a crucial role in promoting equitable access to biologic therapies.

Для цитирования: May Lee Marco, Di Lernia Vito, Peccerillo Francesca, Bardazzi Federico, Tabanelli Michela, Ricci Michela, Melandri Davide, Corazza Monica, Satolli Francesca, Conti Andrea. Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy.. Dermatology reports. 2025. DOI: 10.4081/dr.2025.10315.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.